Similar articles

• Pancreatic exocrine "burnout" following pancreas transplantation.

  Barone GW, Henry ML, Elkhammas EA, Osei K, Tesi RJ, Ferguson RM. Barone GW, et al. Transplant Proc. 1992 Jun;24(3):831-2. Transplant Proc. 1992. PMID: 1376529 No abstract available.
• Limitations in the use of insulin or C-peptide alone in the assessment of beta-cell function in pancreas transplant recipients. Danish-Swedish Study Group of Metabolic Effect of Pancreas Transplantation.

  Christiansen E, Tibell A, Groth CG, Rasmussen K, Pedersen O, Burcharth F, Christensen NJ, Vølund A, Madsbad S. Christiansen E, et al. Transplant Proc. 1994 Apr;26(2):467-8. Transplant Proc. 1994. PMID: 8171508 Review. No abstract available.
• Glucose metabolism in patients after combined kidney-pancreas transplantation.

  Luzi L, Facchini F, Secchi A, Battezzati A, Alemagna S, Ferrari G, Staudacher C, Di Carlo V, Pozza G. Luzi L, et al. Transplant Proc. 1990 Apr;22(2):661. Transplant Proc. 1990. PMID: 2183437 No abstract available.
• Pancreatic allograft function as assessed by IMX first-phase insulin assays.

  Henry ML, Davies EA, Elkhammas EA, Tesi RJ, Osei K, Ferguson RM. Henry ML, et al. Transplant Proc. 1994 Apr;26(2):537. Transplant Proc. 1994. PMID: 8171542 No abstract available.
• Pancreas transplantation for diabetes mellitus.

  Stratta RJ, Larsen JL, Cushing K. Stratta RJ, et al. Annu Rev Med. 1995;46:281-98. doi: 10.1146/annurev.med.46.1.281. Annu Rev Med. 1995. PMID: 7598465 Review.